Insight Molecular Diagnostics (IMDX) Return on Invested Capital (2020 - 2024)

Insight Molecular Diagnostics (IMDX) has 3 years of Return on Invested Capital data on file, last reported at 0.03% in Q3 2024.

• Quarterly Return on Invested Capital changed N/A year-over-year to 0.03% in Q3 2024, while the trailing twelve-month figure through Sep 2024 was 0.03% (changed N/A YoY) and the FY2022 annual result came in at 0.0%, up 1.0% from the prior year.
• Return on Invested Capital eased to 0.03% in Q3 2024 per IMDX's latest filing, from 0.02% in the prior quarter.
• The five-year high for Return on Invested Capital was 0.0% in Q2 2021, with the low at 0.03% in Q3 2024.
• Average Return on Invested Capital over 3 years is 0.01%, with a median of 0.01% recorded in 2020.
• The widest YoY moves for Return on Invested Capital: up 0 bps in 2021, down 0 bps in 2021.
• Insight Molecular Diagnostics' Return on Invested Capital stood at 0.01% in 2020, then increased by 3 bps to 0.01% in 2021, then sank by 232 bps to 0.03% in 2024.
• Business Quant data shows IMDX's Return on Invested Capital at 0.03% in Q3 2024, 0.02% in Q2 2024, and 0.02% in Q1 2024.